Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

PJ34

344458-19-1C17H17N3O2295.342 g/mol

A member of the class of phenanthridines that is 5,6-dihydrophenanthridine substituted at positions 2 and 6 by (N,N-dimethylglycyl)amino and oxo groups, respectively. It is a potent inhibitor of poly(ADP-ribose) polymerases PARP1 and PARP2 (IC50 of 110 nM and 86 nM, respectively) and exhibits anti-cancer, cardioprotective and neuroprotective properties. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number344458-19-1ChEBI ↗
Molecular formulaC17H17N3O2ChEBI ↗
Molar mass295.342 g/molChEBI ↗
Monoisotopic mass295.13208 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:167900ChEBI ↗

Cross-source molecular data

PubChem
Molar mass295.34 g/molPubChem ↗
Exact mass295.132076794 DaPubChem ↗
Computed XLogP1.7PubChem ↗
Topological polar surface area (Ų)61.4PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors3PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
PJ34
2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide
UYJZZVDLGDDTCL-UHFFFAOYSA-N
CN(C)CC(=O)Nc1ccc2nc(=O)c3ccccc3c2c1
InChI=1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22)

Names & synonyms

2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antiatherosclerotic agentantineoplastic agentangiogenesis inhibitorEC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitorneuroprotective agentanti-inflammatory agentapoptosis inducercardioprotective agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00338591 mol

Uses 295.342 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 17 atoms
69.14%
N
Nitrogen · 3 atoms
14.23%
O
Oxygen · 2 atoms
10.83%
H
Hydrogen · 17 atoms
5.80%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:167900

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 4858 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.